Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | IBKR | MS |
|---|---|---|
| Price | $90.05 | $196.75 |
| Change today | ▼ 1.65% | ▼ 0.83% |
| Market cap | $40.80B | $309.01B |
| Return, 3 months | -2.9% | -10.0% |
| Return, year to date | +40.4% | +12.7% |
| Return, 1 year | +40.3% | +27.4% |
| P/E (TTM) | 35.7 | 15.9 |
| P/B | 6.9 | 2.9 |
| P/E percentile vs own 5y | 91st | 64th |
| Dividend yield | 0.36% | 2.03% |
| Revenue growth (YoY, latest qtr) | +21.3% | +27.4% |
| Net profit growth (YoY) | +33.0% | +58.1% |
| Gross margin | 90.2% | – |
| Operating margin | 86.5% | – |
| Net margin | 10.2% | 26.8% |
| Return on equity | 21.0% | 19.1% |
| Analyst target vs. price | +21.5% | +24.8% |
| Analyst buy share | 67% | 57% |
| RSI (14) | 53 | 36 |
| 30-day volatility | 41.1% | 24.1% |
| Max drawdown, 1 year | -18.7% | -18.8% |
| Trend read | Leaning bullish | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.